Package 61958-2501-3

{"route": ["ORAL"], "spl_id": "239a890e-57db-430c-897a-11a7eb9a3611", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["FWF6Q91TZO", "G70B4ETF4S", "4L5MP1Y7W7"], "rxcui": ["1999667", "1999673", "2584354", "2584356"], "spl_set_id": ["664cb8f0-1f65-441b-b0d9-ba3d798be309"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2501-1)", "package_ndc": "61958-2501-1", "marketing_start_date": "20180207"}, {"sample": false, "description": "7 TABLET in 1 BOTTLE, PLASTIC (61958-2501-2)", "package_ndc": "61958-2501-2", "marketing_start_date": "20180726"}, {"sample": false, "description": "30 TABLET in 1 BLISTER PACK (61958-2501-3)", "package_ndc": "61958-2501-3", "marketing_start_date": "20210824"}], "brand_name": "Biktarvy", "product_id": "61958-2501_239a890e-57db-430c-897a-11a7eb9a3611", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "61958-2501", "generic_name": "bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Biktarvy", "active_ingredients": [{"name": "BICTEGRAVIR SODIUM", "strength": "50 mg/1"}, {"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR ALAFENAMIDE FUMARATE", "strength": "25 mg/1"}], "application_number": "NDA210251", "marketing_category": "NDA", "marketing_start_date": "20180207", "listing_expiration_date": "20271231"}